null

Truway Health Clinical Trials

Truway Health Clinical Trials & Research

Advancing Clinical Science. Strengthening Healthcare Systems. Improving Tomorrow's Care.

Research-driven innovation with purpose

At Truway Health, Inc., we believe meaningful healthcare innovation begins with better questions, rigorous investigation, reliable evidence, and an unwavering commitment to patient welfare.

Our clinical and operational research initiatives explore emerging medical technologies, physiologic monitoring, regenerative medicine, precision diagnostics, artificial intelligence, and healthcare infrastructure.

From investigating sensorineural hearing loss and immune-system signaling to studying whole-body digital twins and early indicators of clinical deterioration, our programs aim to expand scientific understanding and identify opportunities for future improvements in healthcare.

Explore Our Research | Inquire About Participation | Partner With Our Team


Our Research Portfolio

1. Hearing Restoration & Regenerative Medicine

HEAR-RESTORE — Inner Ear Trauma, Tinnitus & Sensorineural Hearing Loss

ClinicalTrials.gov: NCT07472023

HEAR-RESTORE investigates regenerative medicine and stem cell-based approaches in the context of inner ear injury, tinnitus, and sensorineural hearing loss.

The research examines questions involving auditory function, treatment safety, biological mechanisms, and the potential for measurable changes in hearing-related outcomes.

The investigational approaches have not been established as safe or effective treatments for hearing restoration.

2. Immunology & Emerging Therapeutics

QSIT — Electromagnetic Immunotherapy Mapping & Cytokine Forecasting

ClinicalTrials.gov: NCT07221565

QSIT explores experimental approaches to immune-system signaling, low-frequency electromagnetic exposure, cytokine dynamics, and machine-learning-assisted biological forecasting.

The study seeks to evaluate proposed mechanisms and measurable biological responses, without presuming that the underlying therapeutic hypotheses have been validated.

3. Digital Health, Physiologic Intelligence & Predictive Medicine

TRU-OMNIBODY — Whole-Body Digital Twin & Physiologic Resilience

ClinicalTrials.gov: NCT07805044

Investigates computational representations of whole-body physiology, integrating information across multiple organ systems to examine resilience, recovery, and emerging health-state changes.

OMNIPHYS — Multimodal Physiologic State Intelligence

ClinicalTrials.gov: NCT07814118

Studies how multiple physiologic measurements may be integrated to characterize health states, individual variability, and changes in functional status.

CLIN-TIME — Clinical Time & Temporal Dynamics

ClinicalTrials.gov: NCT07812831

Investigates whether longitudinal clinical patterns, measurement trajectories, and timing relationships provide additional information beyond isolated clinical observations.

FUSION-72 — Acute Clinical Deterioration Prediction

ClinicalTrials.gov: NCT07817550

Evaluates the potential predictive value of multimodal digital biomarkers for identifying protocol-defined clinical deterioration within a 72-hour observation window.

NFHST — NeuroFinance Human Stress Trial

ClinicalTrials.gov: NCT07622589

Examines physiologic and behavioral responses to financial and informational volatility, including the relationship between stress, cognitive processing, and measurable human responses.

MBAP-X — Mobile Behavioral Activation & Wearable Monitoring

ClinicalTrials.gov: NCT07382804

Explores wearable sensing, activity monitoring, and digital verification approaches within structured behavioral research.

4. Diagnostics, Medical Devices & Clinical Infrastructure

TRU-DX — Diagnostic Tools in Primary Care

ClinicalTrials.gov: NCT07209527

Examines the potential utility of diagnostic technologies and clinical assessment tools within primary-care workflows.

TruVascular Access — Ultrasound-Guided Vascular Access

ClinicalTrials.gov: NCT07798427

Investigates ultrasound-guided vascular-access procedures, procedural performance, and selected patient-care outcomes.

ICE-ACCESS — Intracardiac Echocardiography Supply Reliability

ClinicalTrials.gov: NCT07788040

Explores the relationship between specialized cardiovascular-device supply availability, procedural readiness, and access to clinical services.

Federated Learning for Point-of-Care Cardiac Ultrasound

ClinicalTrials.gov: NCT07800962

Investigates distributed machine-learning approaches for cardiac ultrasound research, with attention to analytical performance and data governance.

HEALTH — Humanoid Robotics in Clinical Care Settings

ClinicalTrials.gov: NCT07214896

Examines proposed applications of humanoid robotics and automation in healthcare operations and clinical workflows.

5. Translational & Laboratory Research

CRYO-IVT — In-Vitro Cryo-Therapeutic Protocols

ClinicalTrials.gov: NCT07321028

Explores the biological effects of controlled cryogenic conditions on human cell samples within laboratory research.

6. Healthcare Integrity & Advanced Research Environments

HIAEP — Healthcare Integrity & Anti-Fraud Enforcement

ClinicalTrials.gov: NCT07217730

Explores healthcare integrity, operational accountability, compliance-related systems, and research approaches to identifying institutional risks.

LUMEN-HAB — Lunar Habitation & Environmental Pathways

ClinicalTrials.gov: NCT07546461

Investigates environmental and operational considerations associated with future human habitation in extreme and extraterrestrial environments.

These operational and environmental initiatives are part of the broader research portfolio; they should not be interpreted as clinical treatment offerings.


Our Scientific Research Priorities

Translating questions into measurable evidence

Our research initiatives are organized around several overarching priorities:

  • Patient-centered investigation: Examining clinically meaningful questions while prioritizing participant rights, safety, and informed consent.

  • Multimodal measurement: Studying relationships among clinical assessments, physiologic signals, laboratory findings, and longitudinal observations.

  • Responsible artificial intelligence: Evaluating computational models through reproducible methods, performance assessment, and appropriate human oversight.

  • Translational research: Investigating scientific mechanisms and emerging technologies without assuming that preliminary findings demonstrate clinical effectiveness.

  • Research integrity: Supporting accurate documentation, protocol adherence, appropriate ethical oversight, privacy safeguards, and transparent reporting.

  • Healthcare systems improvement: Studying diagnostic accessibility, medical-device availability, and operational factors that may affect care delivery.

Our objective is not simply to develop new technologies, but to rigorously evaluate where those technologies may offer reliable, meaningful, and responsible improvements.


Clinical Research Participation

Your health. Your questions. Your informed choice.

We welcome inquiries from individuals interested in learning more about eligible clinical research opportunities.

Each study has its own eligibility criteria, research procedures, participation requirements, and enrollment limitations. Some programs involve observational data collection, while others investigate experimental interventions or technologies.

How the inquiry process works

  1. Explore a research program. Review the study description and public registry record.

  2. Submit an inquiry. Identify the study of interest and provide general contact information.

  3. Discuss eligibility. Where appropriate, the research team can explain available screening procedures and study requirements.

  4. Review participation information. Eligible candidates receive applicable study information and informed-consent materials before deciding whether to participate.

Submission of an inquiry does not guarantee screening, eligibility, enrollment, access to investigational treatment, or medical benefit.

Research status: Listed programs currently have invitation-based enrollment classifications. Availability must be confirmed individually with the research team.

Information for Patients & Caregivers

We recognize that individuals seeking research opportunities may be navigating complex diagnoses, changing health circumstances, or limited treatment options.

Our goal is to communicate study objectives, investigational limitations, eligibility requirements, and the distinction between scientific research and established medical care as clearly as possible.

Please avoid submitting detailed medical records or sensitive health information through an unsecured general contact form. The research team can advise whether a secure submission method is available.

Contact the Clinical Research Team


Institutional Research & Scientific Collaboration

Collaborating across science, technology, and healthcare operations

Truway Health welcomes appropriate collaboration inquiries from healthcare institutions, academic researchers, clinical investigators, diagnostic developers, medical-device manufacturers, biotechnology organizations, and healthcare technology partners.

Areas of collaboration may include clinical study design, scientific validation, laboratory investigation, digital biomarker development, medical-device evaluation, research infrastructure, and healthcare operations.

Potential collaborations are evaluated according to scientific relevance, operational feasibility, applicable oversight, and alignment with program objectives.

Explore Research Partnerships


Our Commitment to Ethical & Responsible Investigation

Clinical research requires more than technical innovation. It requires clear scientific objectives, transparent methods, appropriate participant protections, data integrity, and an honest interpretation of results.

Truway Health's research approach emphasizes protocol-defined investigations, documented methodologies, appropriate ethical and regulatory review, reproducibility, and responsible stewardship of research information.

ClinicalTrials.gov registration is a public research-record mechanism. Registration does not constitute endorsement by the National Institutes of Health, approval by the U.S. Food and Drug Administration, or confirmation that an intervention is safe or effective.

Investigational medical technologies, computational models, regenerative approaches, and experimental procedures must not be represented as clinically validated solely because they are included in a registered study.


Research Inquiries & Contact

Help us explore the next generation of healthcare innovation.

Whether you are a prospective research participant, healthcare professional, academic investigator, institutional partner, or technology developer, Truway Health welcomes inquiries related to our research portfolio.

Please identify the relevant study name or ClinicalTrials.gov identifier and briefly describe the purpose of your inquiry.

Truway Health, Inc. — Clinical Research & Innovation

View Registered Studies on ClinicalTrials.gov

Advancing health through evidence, innovation, integrity, and collaboration.

What is 7 - 4?

TRUWAY HEALTH INSTAGRAM